Allurion Technologies, Inc. Total Assets

Latest as of March 2026: $13.99 Million USD

Allurion Technologies, Inc. total assets. Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) holds total assets worth $13.99 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Allurion Technologies, Inc. (ALUR) total market value for the company's overall valuation and market capitalisation.

Total Assets of Allurion Technologies, Inc. (2020–2025)

Total assets of Allurion Technologies, Inc. from 2020 to 2025. This chart illustrates how Allurion Technologies, Inc.'s total assets have evolved over time, based on quarterly financial data. See ALUR live share price for real-time trading data and today's change.

Allurion Technologies, Inc. - Asset Composition Analysis

Allurion Technologies, Inc. Total Assets Breakdown (December 2025)

Allurion Technologies, Inc. total assets breakdown as of December 2025. Allurion Technologies, Inc.'s total assets of $13.99 Million consist of 81.1% current assets and 18.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 34.3%
Accounts Receivable $3.95 Million 25.1%
Inventory $2.67 Million 16.9%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2020–2025)

This chart illustrates how Allurion Technologies, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Allurion Technologies, Inc. (ALUR) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Allurion Technologies, Inc.'s current assets represent 81.1% of total assets in 2025, an increase from 14.3% in 2020.
  • Cash Position: Cash and equivalents constituted 34.3% of total assets in 2025, up from 14.3% in 2020.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
  • Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.

Allurion Technologies, Inc. Competitors by Total Assets

Key competitors of Allurion Technologies, Inc. based on total assets are shown below.

Company Country Total Assets
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
Vitrolife AB
ST:VITR
Sweden Skr11.30 Billion
Sinocare Inc
SHE:300298
China CN¥6.25 Billion
Shanghai Sanyou Medical Co Ltd
SHG:688085
China CN¥2.34 Billion
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
China CN¥7.51 Billion
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
China CN¥1.79 Billion
TAIDOC TECHNOLOGY CORP
TW:4736
Taiwan NT$13.07 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million

Allurion Technologies, Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.30 2.09 2.78
Quick Ratio 0.25 1.88 2.78
Cash Ratio 0.00 0.00 0.00
Working Capital $-25.95 Million $17.27 Million $1.41 Million

Allurion Technologies, Inc. - Advanced Valuation Insights

This section examines the relationship between Allurion Technologies, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -51.9%
Total Assets $15.77 Million
Market Capitalization $21.01K USD

Valuation Analysis

Below Book Valuation: The market values Allurion Technologies, Inc.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Allurion Technologies, Inc.'s assets decreased by 51.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Allurion Technologies, Inc. (2020–2025)

The table below shows the annual total assets of Allurion Technologies, Inc. from 2020 to 2025.

Year Total Assets Change
2025-12-31 $15.77 Million -51.93%
2024-12-31 $32.81 Million -54.24%
2023-12-31 $71.71 Million +39.60%
2022-12-31 $51.37 Million +30.54%
2021-12-31 $39.35 Million +11825.81%
2020-12-31 $329.96K --

About Allurion Technologies, Inc.

NYSE:ALUR USA Medical Devices
Market Cap
$21.01K
Market Cap Rank
#31780 Global
#6403 in USA
Share Price
$0.02
Change (1 day)
+110.00%
52-Week Range
$0.01 - $7.48
All Time High
$10.69
About

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring to… Read more